Thursday, February 13, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $BHNG.C) (TSXV: $NDVA.V) (TSXV: $LIFT.V) (TSXV: $TBP.V) (TSXV: $FLWR.V)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $BHNG.C) (TSXV: $NDVA.V) (TSXV: $LIFT.V) (TSXV: $TBP.V) (TSXV: $FLWR.V)

Delta, Kelowna, BC, February 13, 2020 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few early announcements.

Bhang Inc. (CSE: BHNG) (OTCQX: BHNGF), a global cannabis CPG brand company with an extensive, award-winning portfolio of products, announced that its cannabis-infused milk and dark chocolates are now available for sale in Canada through its joint venture with Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF).

Bhang’s chocolate can be purchased in Ontario, Alberta and Saskatchewan and will soon be available in Manitoba and Nova Scotia.

As previously announced in April 2018, Indiva and Bhang have a 50/50 joint venture to produce and distribute Bhang Chocolate. Through the joint venture, Indiva creates Bhang Chocolate in its state-of-the-art facility based in London, Ontario. Each chocolate contains 10 mg of tetrahydrocannabinol (THC) and comes from sustainably sourced cacao. Chocolates are scored into four pieces, so they are perfect for sharing. Looking ahead, Bhang and Indiva intend to bring cannabidiol (CBD) chocolates to Canadian consumers later in the year.

“We’re fortunate to have established partners like Indiva to help us provide Canadian consumers with the highest quality of edibles available in the recently launched Cannabis 2.0 market,” said Bhang President & CEO Jamie Pearson. “Deloitte analysts estimate that the Canadian market for edibles, extracts and topicals could be worth C$2.7 billion annually, with cannabis edibles accounting for C$1.6 billion alone. We see significant opportunity in the Canadian market and are proud to bring our exceptional chocolate to our friends up north.”

In addition to its Canada joint-venture, Bhang’s multi-state cannabis platform includes licensees in Florida, Nevada, Michigan, New Mexico, Illinois and Ohio. The Company’s hemp-derived CBD products are available throughout the U.S. in brick & mortar stores and online as well as in Puerto Rico, Germany, Austria, Switzerland, Poland, and the U.K.

In the decade since Bhang was founded, the company has received dozens of top honors for its edible cannabis and cannabidiol-based products. Most recently, Bhang won the Best Cannabis-Infused Chocolate Award at WeedCon West 2019 as well as Best Cannabis Chocolate in New Mexico from Dank Magazine. Other top edible honors included numerous High Times Cannabis Cup Best of Awards, and acknowledgments from a diverse range of competitions such as the Medical Cup, Chalice Cup, Patients Choice and the 805 Cannabud Cup, among many others.

Bhang’s brand portfolio of 100+ cannabis, hemp-derived CBD and non-cannabis products includes an assortment of chocolate, tinctures, pre-roll straights, gum, capsules, gummies as well as range of organic beverages and powders spanning the lifestyle segment through its wholly owned subsidiary Red Ace Organics.

Lift & Co. (TSXV: LIFT) (OTCQB: LFCOFannounced key updates for Cohesion, the Company’s cannabis consumer insights platform. Starting today, Cohesion clients can build custom, real-time dashboards using more than 100 available dimensions to better meet the specific needs of organizations of any size. Insights can be easily shared across teams at all levels to align businesses to a single source of truth.
“We are at a pivotal moment where marketing dollars for cannabis companies need to go further than they ever have,” said Matei Olaru, CEO of Lift & Co. “Cohesion is a timely solution in today’s market that will accurately track sales, enable custom consumer segmentation and deploy targeted digital marketing to these segments all in one place. Today’s major release enables organizations of all sizes and budgets to improve their marketing efficiency, impacting both top-line and bottom-line performance.”
Cohesion draws from Lift & Co.’s millions of cannabis consumer and budtender data points, accumulated over the past five years through verified reviews, purchase receipts and brand research, and on the and CannSell platforms. Unlike traditional CPG and cannabis data providers, Lift & Co.’s combination of actively and passively collected behavioural data (e.g. purchases) and attitudinal data (e.g. product sentiment) at a single source provides a 360-degree view for consumer insights. To gain an even deeper competitive edge, Cohesion clients can also compare their own brand to their competitors’ along each dataset.
Lift & Co.’s data sources inform three primary dashboards on Cohesion:
     Purchase behaviour: Sales tracking, market share, basket size and composition, consumer demographics, and more.
     Product sentiment: Detailed product review and rating insights (volumes and analysis), repeat purchase intent, and more.
     Brand equity: Overall brand awareness including sentiment, brand value, perception, and more.
"Leveraging data is the best way consumer brands can get a competitive advantage but, too often, too many resources are spent sourcing, stitching together and analyzing the data just to deliver those insights to the business,” said Sean Copeland, VP of Data, Lift & Co. “Cohesion will make any product or marketing cycle more efficient by enabling the gathering of key consumer insights, advertising directly to target audiences, and tracking the success of those campaigns on one platform. The emergence of a major new industry has created new data intelligence opportunities and we’re delivering on that with Cohesion.”
With today’s release of Version 2, Cohesion clients can manipulate any combination of metrics from these three primary datasets on their own dashboards, personalized to their strategy, to answer common questions such as:
     How did my most recent marketing campaign elevate brand awareness?
     How does market share currently break down by brand, and is my brand’s market share trending up or down?
     How likely are consumers to purchase my product(s)? How will this affect my top line?
     Who is my consumer and what else do they buy?
More than 30 Canadian cannabis brands are on the Cohesion platform since it launched in September 2019. Following the introduction of consumer purchase receipt uploading to Lift & Co. in 2018, and the addition of high-value rewards like travel contests, the Company has had an accelerated increase in data volume with a 498% increase in total submitted receipts and 326% increase in total reviews for the three-month period ended December 31, 2019 compared to the previous year. This increased volume has resulted in improved accuracy on Cohesion with a margin of error of +/- 5% at a 95% confidence level for the top 50 brands in Canada.
Also launching in 2020 is Cohesion Segmentation - powered by Nielsen, which will combine Lift & Co. cannabis data with Nielsen’s CPG consumer insights. Brands will be able to identify custom consumer segments based on cannabis and non-cannabis buyer trends, and track how they and their competitors’ brands interact with those segments. Cohesion Segmentation will also include Adobe Advertising Cloud’s DSP to seamlessly deliver programmatic, compliant digital advertising to targeted consumers. This brings much-needed industry-standard advertising solutions to cannabis, as well as the ability to track the results of those campaigns on Cohesion dashboards. With these enhancements, the Company estimates that Cohesion clients will be able to increase click-through-rates by over 20% and reduce digital customer acquisition costs by as much as 30%.
Listen to Investorideas recent podcast interview with Matei Olaru here.

Tetra Bio Pharma Inc. (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, announced it has signed a definitive manufacturing agreement with Vitiprints LLC, for the commercial scale production of CAUMZ™ and HCC011.  This agreement will further protect CAUMZ™ and HCC011 with four additional patents on manufacturing know-how.

VITIPRINTS has developed a proprietary and patented manufacturing system, which can be used by Tetra to manufacture its CAUMZ™ drug on commercial scale.  As part of the manufacturing agreement Tetra has obtained a Vitiprints exclusive license to use this technology for commercial manufacturing CAUMZ™ and HCC-011 at high speed and volume in a manner that will permit it to be used in a vaporization system (CAUMZ™ kit).  This proprietary technology will operate under pharmaceutical GMP (Good Manufacturing Practices) regulations and will ensure a "pill-to-pill" consistency that meets inhalation drug standards.

In exchange of this exclusive license Tetra will be required to make milestones and royalty payments on CAUMZ™ sales.  From a financial standpoint this proprietary technology will allow Tetra to reduce it Cost of Goods Sold (COGS) for CAUMZ™ by approximately 75% and will significantly improve CAUMZ™ gross margin.

Vitiprints will perform a thorough assessment of the Quantum Facility in Moncton next week with an objective of implementing its technology in the spring for the production of commercial batches.  “The previous technology used for the manufacturing process was excellent but unfortunately it was limited by its maximal batch size capacity.” said Dr. Guy Chamberland, Tetra Bio-Pharma’s CEO and Chief Regulatory Officer.  “In a first phase of implementation, Tetra’s production capacity will increase from 2,500 dosing capsules in a 3-day shift to 100,000 CAUMZ™ dosage units in a single 8-hour shift.  The second phase will involve a scale-up and transfer of this proprietary technology to a Greater Montreal Pharmaceutical facility.”

"Tetra is now moving full speed into the implementation of it commercial manufacturing of its key assets CAUMZ™ and HCC011.  This agreement provides Tetra with high speed and volume and flexibility to meet the global demand for CAUMZ™ and HCC-011.  Tetra must manufacture batches of CAUMZ™ using its commercial manufacturing process to complete the quality section of the New Drug Application.  It is very important for Tetra to ensure it can meet the global demand of patients who are suffering from cancer.  Back orders are not an option!” said Dr. Guy Chamberland, Tetra Bio-Pharma’s CEO and Chief Regulatory Officer.

Also if you are looking for a good overall presentation on the Cannabis space click the link here to see The Flower Corporation’s (TSXV: FLWR) 202 Investor Presentation which includes a great graph of some of the top cannabis companies’ capital raises versus expenses.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at

To hear more podcasts visit: podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and
Global investors must adhere to regulations of each country. Please read privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

No comments:

Post a Comment